| Date | Investigators | Affiliation | Project Title |
Mar 2008
Due Sept 2008
|
D. Huntsman
|
University of British Columbia
|
TMPRSS2-ERG in BRCA2 associated prostate cancers
|
April 2008
Due Oct 2008
|
P.M. O’Brien, N.F. Hacker, S.J. Clark, J.P. Scurry
|
Garvan Institute
|
DNA methylation alterations in early ovarian carcinogenesis
|
29 May 2008
Due November 2008
|
Logan Walker and Mandy Spurdle
|
QIMR, Royal Brisbane Hospital QLD
|
Investigation of copy number variants and familial breast cancer risk, and their interaction with rare BRCA1/2 sequence variants.
|
29th May 2008
Due November 2008
|
Georgia Trench and Mandy Spurdle
|
QIMR, Royal Brsibane Hospital
|
Collaborative Ovarian, Prostate and Breast Gene-environment Study (COGS)
|
17th June 2008
Due December 2008
|
Damien Bolton, David Clouston, Ian Campbell, Stephen Fox, John Hopper, Gillian Mitchell et al
|
Austin Hospital Melbourne, Tissupath Melbourne, The University of Melbourne, Peter MaCallum Cancer Centre Melbourne
|
Prostate Cancer in BRCA2 mutation carriers.
|
July 2008
January 2009
|
Tom Gonda and Rob Ramsay
|
University of Queensland and PeterMacCallum Cancer Centre
|
The function of the MYB oncogene in breast cancer
|
A pilot or full application must be made within 6 months of submitting the letter
of intent. If more than six months has elapsed, a new letter of intent must be submitted
prior to the full application.
